Case number 2021-2335
Celgene Corporation v. Hetero Labs Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 22, 2021 | 13 | MOTION of Appellant Celgene Corporation to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 11/22/2021 by email. [814078] [21-2335] [Francis Cerrito] [Entered: 11/22/2021 12:56 PM] (3) |
| Nov 22, 2021 | 14 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [13] filed by Appellant Celgene Corporation.; issuing mandate. Service as of this date by the Clerk of Court. [814097] [JCW] [Entered: 11/22/2021 01:46 PM] (2) |
| Oct 15, 2021 | 12 | Official caption revised to reflect non-appearance of Appellees Apotex Corp., Apotex Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Breckenridge Pharmaceutical, Inc., Eugia Pharma Specialties Limited, Hetero Drugs Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA, Inc. (see attached). Service as of this date by the Clerk of Court. [806045] [JCW] [Entered: 10/15/2021 01:58 PM] (2) |
| Oct 12, 2021 | 10 | Notice to Appellees Apotex Corp., Apotex Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Breckenridge Pharmaceutical, Inc., Eugia Pharma Specialties Limited, Hetero Drugs Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA, Inc.: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, and/or Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [804946] [JCW] [Entered: 10/12/2021 01:24 PM] (0) |
| Oct 12, 2021 | 11 | Corrected Docketing Statement for the Appellant Celgene Corporation. Service: 10/12/2021 by email. [804995] [21-2335] [Francis Cerrito] [Entered: 10/12/2021 02:36 PM] (2) |
| Oct 6, 2021 | 8 | Official caption revised to add Mylan Pharmaceuticals, Inc., Mylan Inc. and Mylan N.V. to the case. (see attached). Service as of this date by the Clerk of Court. [803911] [JCW] [Entered: 10/06/2021 11:18 AM] (2) |
| Oct 6, 2021 | 9 | Docketing Statement for the Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals, Inc.. Service: 10/06/2021 by email. [803999] [21-2335] [Tung Kong] [Entered: 10/06/2021 02:10 PM] (2) |
| Oct 5, 2021 | 2 | Entry of appearance for F. Dominic Cerrito; Eric C. Stops; Frank C. Calvosa; Ellyde R. Thompson; Jennifer L. Swize; Matthew J. Hertko as counsel for Appellant Celgene Corporation. Service: 10/05/2021 by email. [803681] [21-2335] [Francis Cerrito] [Entered: 10/05/2021 01:25 PM] (2) |
| Oct 5, 2021 | 3 | Docketing Statement for the Appellant Celgene Corporation. Service: 10/05/2021 by email. [803682] [21-2335] This document is non-compliant. See Doc No.[5] [Francis Cerrito] [Entered: 10/05/2021 01:26 PM] (2) |
| Oct 5, 2021 | 4 | Certificate of Interest for Appellant Celgene Corporation. Service: 10/05/2021 by email. [803683] [21-2335] [Francis Cerrito] [Entered: 10/05/2021 01:28 PM] (4) |
| Oct 5, 2021 | 5 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Celgene Corporation, Docketing Statement [3], is not in compliance with the rules of this court (see attached). Compliant document due on 10/13/2021. Service as of this date by the Clerk of Court. [803713] [JCW] [Entered: 10/05/2021 02:07 PM] (1) |
| Oct 5, 2021 | 6 | Entry of appearance for Tung-On Kong; Elham F. Steiner; Kristina M. Hanson; Steffen N. Johnson as counsel for Mylan Pharmaceuticals, Inc.; Mylan Inc.; Mylan N.V.. Service: 10/05/2021 by email. [803845] [21-2335] [Tung Kong] [Entered: 10/05/2021 08:11 PM] (2) |
| Oct 5, 2021 | 7 | Certificate of Interest for Mylan Pharmaceuticals, Inc.; Mylan Inc.; Mylan N.V.. Service: 10/05/2021 by email. [803846] [21-2335] [Tung Kong] [Entered: 10/05/2021 08:13 PM] (3) |
| Sep 21, 2021 | 1 | Appeal docketed. Received: 09/20/2021. [800909]Entry of Appearance is due on 10/05/2021. Certificate of Interest is due on 10/05/2021. Docketing Statement is due on 10/05/2021. Appellant's brief is due on 11/22/2021. [JCW] [Entered: 09/21/2021 04:46 PM] (119) |
